Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  3. Research Domains
  5. Chemical Sciences
  7. Medicinal And Biomolecular Chemistry
  9. Medicinal And Biomolecular Chemistry Not Elsewhere Classified
  11. Suloctidil-induced Hepatotoxicity.

Suloctidil-induced hepatotoxicity.

M W Chung1, R A Komorowski, R R Varma

  • 1Department of Medicine, Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital, Milwaukee.

Gastroenterology
|August 1, 1988

Related Experiment Videos

View abstract on PubMed

Summary
This summary is machine-generated.

Suloctidil, a drug for dementia and thrombotic disorders, can cause liver damage (hepatotoxicity). This case highlights the importance of recognizing suloctidil-induced hepatotoxicity through liver tests and biopsy.

Area of Science:

  • Pharmacology
  • Hepatology
  • Clinical Medicine

Background:

  • Suloctidil is under investigation for dementia and thrombotic disorders.
  • Hepatotoxicity reports for suloctidil are primarily from European literature.
  • Histologic data on suloctidil-induced liver injury is limited and often in French.

Observation:

  • This report details a case of suloctidil-induced hepatotoxicity.
  • The case was documented using serum liver biochemical tests.
  • Liver biopsy provided crucial histologic evidence.

Findings:

  • Histologic examination revealed focal hepatocyte necrosis.
  • Mild Kupffer cell hyperplasia was observed.
  • Features were consistent with mild acute hepatitis.

Related Experiment Videos

Related Concept Videos

Implications:

  • This case contributes to understanding suloctidil's potential adverse effects.
  • It underscores the need for vigilance regarding drug-induced liver injury.
  • Further research may be warranted to fully characterize suloctidil hepatotoxicity.